Q1 2025 Earnings Call Transcript May 13, 2025 Biodesix, Inc. reports earnings inline with expectations. Reported EPS is ...

ProMIS Neurosciences Inc. , a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, ...

RIZE enrollment on track including U.S. sites and expected to be completed in May 2025; topline data anticipated in December 2025 U.S. F ...

Following a pre-specified interim analysis, an independent Data Safety Monitoring Board (DSMB) recommended the pivotal Phase 3 trial (DR ...

Many investors have never heard of Eurofins Scientific, yet this French-based global leader in testing is woven into the ...

Welcome to the Conference Call hosted by Daré Bioscience to review the company's First Quarter 2025 Financial Results and to provide the Business Update. This call is being recorded. My name is Gayle ...

First Cohort Completed in PRECISE-AD Trial Evaluating PMN310 in Alzheimer's Disease Six Month Interim Results Expected in 1H 2026 Topline Results Anticipated by end of 2026 CAMBRIDGE, Massachusetts ...

Results We identified between 103 and 888 HLA-DR-naturally presented peptides per sample. We selected 37 native and six citrullinated (cit)-peptides for stimulation assays. Six of these peptides ...

Automated Payment Plans: Healthcare providers can offer automatic payment plans as an alternative to allowing unpaid invoices ...

Dr. Gu joined forces with two AI experts to launch Youlify, a physician-led startup aimed at modernizing the way healthcare ...

A Rutgers Health review of 151 studies finds that minimizing unexplained symptoms sparks shame, trauma and avoidance of care.

Republican lawmakers in the state House of Representatives have introduced a bill seeking to limit confidentiality between ...